Job titles of the future: Nature’s drug designer
Illustrates AI's expanding role in scientific research - minimal direct relevance to APS AI governance or policy.
Key points
- A University of Michigan professor uses AlphaFold and robotics to design drugs for wildlife and conservation.
- AI-accelerated drug design for non-human patients is a novel research application, not an APS governance concern.
- No direct relevance to Australian public sector AI governance, strategy, or policy work.
View original source
Copied.
"Job titles of the future: Nature’s drug designer"
Source: MIT Technology Review – AI
Published: 11 June 2026
URL: https://www.technologyreview.com/2026/06/11/1138502/job-titles-natures-drug-designer-tim-cernak/
MIT Technology Review profiles Tim Cernak, an associate professor at the University of Michigan who applies AI-assisted drug design tools - including Google DeepMind's AlphaFold - to wildlife and conservation medicine. Using protein-modelling software and laboratory robotics, he develops treatments for species such as loggerhead sea turtles and Gila monsters, and is working on precision insecticides for trees. He frames this emerging field as 'conservation chemistry.' The item is a human-interest science profile with no substantive APS policy or governance angle.
Retrieved from SIMS, 18 July 2026.